These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of phosphonoacetic acid on the in vitro replication of varicella-zoster virus. May DC; Miller MR; Rapp F Intervirology; 1977; 8(2):83-91. PubMed ID: 192695 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus. Preissner CM; Steinberg SP; Gershon AA; Smith TF J Clin Microbiol; 1982 Aug; 16(2):373-6. PubMed ID: 6288766 [TBL] [Abstract][Full Text] [Related]
5. Replication of varicella zoster virus in primary human keratinocytes. Sexton CJ; Navsaria HA; Leigh IM; Powell K J Med Virol; 1992 Dec; 38(4):260-4. PubMed ID: 1335482 [TBL] [Abstract][Full Text] [Related]
6. Infection and persistence of varicella-zoster virus in lymphoblastoid Raji cell line. Leventon-Kriss S; Gotlieb-Stematsky T; Vonsover A; Smetana Z Med Microbiol Immunol; 1979; 167(4):275-83. PubMed ID: 232537 [TBL] [Abstract][Full Text] [Related]
7. Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections. Gallo D; Schmidt NJ J Clin Microbiol; 1981 Nov; 14(5):539-43. PubMed ID: 6273453 [TBL] [Abstract][Full Text] [Related]
8. Appearance of immunoglobulin G Fc receptor in cultured human cells infected with varicella-zoster virus. Ogata M; Shigeta S Infect Immun; 1979 Nov; 26(2):770-4. PubMed ID: 232695 [TBL] [Abstract][Full Text] [Related]
9. Formation of varicella-zoster virus antigens in infected Vero cells. Takayama M; Oya A Microbiol Immunol; 1985; 29(7):635-43. PubMed ID: 3003545 [TBL] [Abstract][Full Text] [Related]
10. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster. Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973 [TBL] [Abstract][Full Text] [Related]
11. Varicella-zoster virus infection of human astrocytes, Schwann cells, and neurons. Assouline JG; Levin MJ; Major EO; Forghani B; Straus SE; Ostrove JM Virology; 1990 Dec; 179(2):834-44. PubMed ID: 2173263 [TBL] [Abstract][Full Text] [Related]
12. Varicella-zoster virus-induced transformation of mammalian cells in vitro. Gelb L; Dohner D J Invest Dermatol; 1984 Jul; 83(1 Suppl):77s-81s. PubMed ID: 6330228 [TBL] [Abstract][Full Text] [Related]
13. Effects of tumor necrosis factor alpha on replication of varicella-zoster virus. Ito M; Nakano T; Kamiya T; Kitamura K; Ihara T; Kamiya H; Sakurai M Antiviral Res; 1991; 15(3):183-92. PubMed ID: 1653555 [TBL] [Abstract][Full Text] [Related]
18. Complement-fixing antigens produced by varicella-zoster virus in tissue culture. Martin ML; Palmer EL Appl Microbiol; 1973 Sep; 26(3):410-6. PubMed ID: 4356464 [TBL] [Abstract][Full Text] [Related]
19. A simplified immunofluorescence technique for antibody to varicella-zoster membrane antigen (FAMA). Baba K; Yoshida M; Tawa A; Yabuuchi H; Maeda K; Takahashi M Biken J; 1984 Mar; 27(1):23-9. PubMed ID: 6091617 [TBL] [Abstract][Full Text] [Related]
20. Anticomplement immunofluorescence for the titration of antibody to varicella-zoster virus. Shigeta S; Baba M; Ogata M; Iijima S; Murai C Microbiol Immunol; 1981; 25(3):295-303. PubMed ID: 6166838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]